(Q35874148)

10 August 2017

1 reference

title

A treatment algorithm for neuropathic pain (English)

1 reference

10 August 2017

0 references

Mike Namaka

1

1 reference

10 August 2017

Colin R Gramlich

2

1 reference

10 August 2017

Dana Ruhlen

3

1 reference

10 August 2017

Maria Melanson

4

1 reference

10 August 2017

Ian Sutton

5

1 reference

10 August 2017

Joanne Major

6

1 reference

10 August 2017

publication date

1 July 2004

1 reference

10 August 2017

published in

Clinical Therapeutics

1 reference

10 August 2017

volume

26

1 reference

10 August 2017

issue

7

1 reference

10 August 2017

page(s)

951-979

1 reference

The induction of pain: an integrative review

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Pain in multiple sclerosis: an overview of its nature and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Cell type and conduction velocity of rat primary sensory neurons with calcitonin gene-related peptide-like immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Role of different peripheral components in the expression of neuropathic pain syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Brain-derived TNFalpha mediates neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Neurons undergo apoptosis in animal and cell culture models of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Acute glucose deprivation leads to apoptosis in a cell model of acute diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Thyroid hormone reduces the loss of axotomized sensory neurons in dorsal root ganglia after sciatic nerve transection in adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Peripheral nerve injury triggers central sprouting of myelinated afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Pharmacologic treatment of complex regional pain syndrome I: a conceptual framework.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Upregulation of Sodium Channel Nav1.3 and Functional Involvement in Neuronal Hyperexcitability Associated with Central Neuropathic Pain after Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Anticonvulsants in neuropathic pain: rationale and clinical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Molecular basis of an inherited epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

1 reference

7 January 2021

Diagnosis and Treatment of Neuropathic Pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Pharmacological management of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Pharmacologic treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Efficacy of sustained-release bupropion in neuropathic pain: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Management of painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Desipramine relieves postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Treatment of post-herpetic neuralgia: antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

The safety of dextromethorphan in pregnancy : results of a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Amitriptyline inhibits voltage-sensitive sodium currents in rat gastric sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Tricyclic antidepressants inhibit voltage-dependent calcium channels and Na(+)-Ca2+ exchange in rat brain cortex synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Amitriptyline versus placebo in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lack of effect of mianserin on the symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

The analgesic effect of codeine as compared to imipramine in different human experimental pain models

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

The psychopharmacologic treatment of depression and anxiety in the context of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Cyclic antidepressants and the risk of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

SSRI Antidepressant Medications: Adverse Effects and Tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Antidepressant-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Neurobiology of neuropathic pain: mode of action of anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

The pharmacological basis of contemporary pain management

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Anticonvulsants: aspects of their mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Glutamate antagonists for treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A summary of mechanistic hypotheses of gabapentin pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Different types of calcium channels mediate central synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Phenytoin in the treatment of diabetic symmetrical polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Use of anticonvulsants for treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Clinical trial of carbazepine (tegretol) in trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Carbamazepine in the treatment of neuralgia. Use of side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Interactions between antiepileptic drugs and hormonal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

The rationale and use of topiramate for treating neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Topiramate relieves refractory trigeminal neuralgia in MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lack of effect of topiramate for central pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lamotrigine in spinal cord injury pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lamotrigine in the management of neuropathic pain: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lamotrigine in the treatment of painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A cost minimization study comparing vigabatrin, lamotrigine and gabapentin for the treatment of intractable partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin for relief of neuropathic pain related to anticancer treatment: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin: a new tool in the treatment of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin use in neuropathic pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Cost-effectiveness of antiepileptic drugs in migraine prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Gabapentin for therapy of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Newer antiepileptic drugs and cognitive issues

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Changes in body weight with chronic, high-dose gabapentin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Pharmacokinetics of gabapentin in subjects with various degrees of renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Drug Prescribing in Renal Failure: Dosing Guidelines for Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Indices of drug misuse for prescription drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Drug interactions with antiepileptic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Treatment issues for women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Topical Capsaicin in Painful Diabetic Neuropathy: Effect on Sensory Function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Topical capsaicin in the management of HIV-associated peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Use of lidocaine patch 5% for chronic low back pain: a report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Chronic pain: 1. A new disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

An old acquaintance: opioids in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Oral opioid therapy for chronic peripheral and central neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Chronic pain states: pathophysiology and medical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Tramadol has no effect on cortical renal blood flow--despite increased serum catecholamine levels--in anesthetized rats: implications for analgesia in renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Opioid switch to oral methadone in cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Meperidine: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Meperidine as a potential cause of serotonin syndrome in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Einsatz von Opioiden bei Leber- oder Niereninsuffizienz

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Motion--Cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs are as safe as placebo for the stomach: arguments against the motion

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Pharmacology of oral combination analgesics: rational therapy for pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Dextromethorphan and diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Analgesic effect of dextromethorphan in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Effects of low-dose ketamine on neuropathic pain: An electroencephalogram-electrooculogram/behavioral study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Effect of benzopyranoperidine, a Δ-9-THC congener, on pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Mexiletine in the Symptomatic Treatment of Diabetic Peripheral Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A comparison of intrathecally administered narcotic and nonnarcotic analgesics for experimental chronic neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Analgesic Action of Acute and Chronic Intraspinally Administered Opiate and α<sub>2</sub>-Adrenergic Agonists in Chronic Neuropathic Pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

No tolerance to the antinociceptive action of calcitonin in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Intrathecal lithium reduces neuropathic pain responses in a rat model of peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Effect of imipramine on tolerance to morphine antinociception in the formalin test

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Temporal factors in the enhancement of morphine analgesia by desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Transcutaneous electrostimulation: emerging treatment for diabetic neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

Spinal cord lesion after long-term intrathecal clonidine and bupivacaine treatment for the management of intractable pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990171-3

7 January 2021

10.1016/S0149-2918(04)90171-3

Identifiers

DOI

1 reference

10 August 2017

1 reference